Abstract:A new series of 6-substituted 1 H -benzimidazole derivatives were synthesized by reacting various substituted aromatic aldehydes with 4-nitro- o -phenylenediamine and 4-chloro- o -phenylenediamine through condensation using sodium metabisulfite as the oxidative reagent. The N-substituted 6-(chloro/nitro)-1 H -benzimidazole derivatives were prepared from the 6-substituted 1 H -benzimidazole derivatives and substituted halides using potassium carbonate by conventional methods as well as by exposure to microwave irradiation. Seventy-six 1 H -benzimidazole derivatives have been synthesized in moderate to excellent yields with the microwave-assisted method (40 to 99%). Compounds 1d , 2d , 3s , 4b , and 4k showed potent antibacterial activity against Escherichia coli , Streptococcus faecalis , MSSA (methicillin-susceptible strains of Staphylococcus aureus ), and MRSA (methicillin-resistant strains of Staphylococcus aureus ) with MIC (the minimum inhibitory concentration) ranging between 2 and 16 μg mL −1 as compared to ciprofloxacin (MIC = 8–16 μg mL −1 ), in particular compound 4k exhibits potent fungal activity against Candida albicans and Aspergillus niger with MIC ranging between 8 and 16 μg mL −1 compared with the standard drug fluconazole (MIC = 4–128 μg mL −1 ). In addition, compounds 1d , 2d , 3s , 4b , and 4k also showed the strongest anticancer activity among the synthesized compounds against five tested cell lines with IC 50 (half-maximal inhibitory concentration) ranging between 1.84 and 10.28 μg mL −1 , comparable to paclitaxel (IC 50 = 1.38–6.13 μM). Furthermore, the five most active compounds showed a good ADMET (absorption, distribution, metabolism, excretion, and toxicity) profile in comparison to ciprofloxacin, fluconazole, and paclitaxel as reference drugs. Molecular docking predicted that dihydrofolate reductase protein from Staphylococcus aureus is the most suitable target for both antimicrobial and anticancer activities, and vascular endothelial growth factor receptor 2 and histone deacetylase 6 are the most suitable targets for anticancer activity of these potent compounds.

Synthesis and Biological Activities of 1-Alkyl-2-methyl-4(5)-nitroimidazole Derivatives

Synthesis and Biological Evaluation of New Compounds with Nitroimidazole Moiety

Synthesis and Study of the Biological Activity of New Compounds Derived from 4-(5-Phenyl-1,3,4-oxadiazole-2-yl)aniline

Synthesis and Antitumor Activity of Indolemalylimide Derivatives

Synthesis, Antiproliferative Evaluation, and Molecular Docking of Thieno[3,2-e]indazole Derivatives

Design, synthesis, bio-evaluation, and in silico studies of some N-substituted 6-(chloro/nitro)-1H-benzimidazole derivatives as antimicrobial and anticancer agents

Synthesis, molecular docking, enzyme inhibition and antioxidant potential of new 1H-benzo[ d ]imidazole-5-carboxamide derivatives

Synthesis and Biological Activities of Imidazolo[2,1-b]-1,3,4-thiadiazole, S-Triazole[3,4-b]-1,3,4-thiadiazole Derivatives Bearing 1H-1,2,4-triazole

The synthesis and antitumor activity of novel 1-alkyl-3-phenyland 3-alkyl-1-phenylimidazothiazolotriazines

2‐(1‐Methyl‐1H‐indazol‐5‐yl)‐N‐arylisonicotinamide Analogs: Synthesis, Anticancer Screening, SAR and ADMET Studies

Synthesis of New 5-Nitroimidazoles Highly Active Against Anaerobes by Substitution Reactions which Proceed via Radical and Radical-Anion Intermediates

Synthesis and Characterization of Some New 4-Methyl-5-Imidazole Carbaldehyde Derivatives

Synthesis and structure-activity relationships of N-methyl-5,6,7-trimethoxylindoles as novel antimitotic and vascular disrupting agents.

Synthesis and biological evaluation of 3,4-diaryl-5-aminoisoxazole derivatives.

Synthesis and in Silico Studies of Some New 1,2,3-Triazolyltetrazole Bearing Indazole Derivatives as Potent Antimicrobial Agents

Synthesis and Preliminary Studies of Biological Activity

Design, Synthesis and In-Vitro Antimicrobial and Cytotoxic Activity Screening of 5-Carboxamide Substituted 3, 4-Dihydropyrimidine-2 (1H) Ones

Imidazole-Derived Alkyl and Aryl Ethers: Synthesis, Characterization, In Vitro Anticancer and Antioxidant Activities, Carbonic Anhydrase I-II Inhibition Properties, and In Silico Studies

Synthesis and biological evaluation of sulfonamide derivatives containing imidazole moiety as ALK5 inhibitors

Synthesis and anticancer activity evaluation of some novel imidazo[1,2-a]pyridine based heterocycles containing S-alkyl/aryl moiety

Synthesis and Anti-tumor Activity of Novel 2-Amino-1,3,4-thiadiazole Derivativers